Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.
Gentzler RD, Evens AM, Rademaker AW, Weitner BB, Mittal BB, Dillehay GL, Petrich AM, Altman JK, Frankfurt O, Variakojis D, Singhal S, Mehta J, Williams S, Kaminer L, Gordon LI, Winter JN. Gentzler RD, et al. Among authors: dillehay gl. Br J Haematol. 2014 Jun;165(6):793-800. doi: 10.1111/bjh.12824. Epub 2014 Mar 15. Br J Haematol. 2014. PMID: 24628515 Free article.
Patterns of Failure and Survival Outcomes after Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin Lymphoma.
Paudel N, Schulze D, Gentzler RD, Evens AM, Helenowski I, Dillehay G, Frankfurt O, Mehta J, Donnelly ED, Gordon LI, Winter JN, Mittal BB. Paudel N, et al. Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):436-446. doi: 10.1016/j.ijrobp.2019.02.007. Epub 2019 Feb 11. Int J Radiat Oncol Biol Phys. 2019. PMID: 30763660 Clinical Trial.
Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project.
Cutler CS, Bailey E, Kumar V, Schwarz SW, Bom HS, Hatazawa J, Paez D, Orellana P, Louw L, Mut F, Kato H, Chiti A, Frangos S, Fahey F, Dillehay G, Oh SJ, Lee DS, Lee ST, Nunez-Miller R, Bandhopadhyaya G, Pradhan PK, Scott AM. Cutler CS, et al. J Nucl Med. 2021 Mar;62(3):422-430. doi: 10.2967/jnumed.120.247197. Epub 2020 Jul 9. J Nucl Med. 2021. PMID: 32646881 Free PMC article.
Practice guideline for the performance of therapy with unsealed radiopharmaceutical sources.
Dillehay GL, Ellerbroek NA, Balon H, Brill DR, Grigsby PW, Macklis RM, Mauch PM, Mian TA, Potters L, Silberstein EB, Williams TR, Wong JC, Gaspar LE; American Society for Therapeutic Radiology and Oncology. Dillehay GL, et al. Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1299-307. doi: 10.1016/j.ijrobp.2005.11.003. Epub 2006 Feb 10. Int J Radiat Oncol Biol Phys. 2006. PMID: 16472933 No abstract available.
Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer.
Nagda SN, Mohideen N, Lo SS, Khan U, Dillehay G, Wagner R, Campbell S, Flanigan R. Nagda SN, et al. Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):834-40. doi: 10.1016/j.ijrobp.2006.09.026. Int J Radiat Oncol Biol Phys. 2007. PMID: 17293236
33 results